Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.25% is 57% below its 5-year average of 17.04%, near the low end of its 5-year range (7.25%–31.98%).
63.59% below its 12-month average of 19.91%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
7.25%
RETURN ON ASSETS (ROA) AVG TTM
19.91%
RETURN ON ASSETS (ROA) AVG 3Y
18.29%
RETURN ON ASSETS (ROA) AVG 5Y
17.04%
RETURN ON ASSETS (ROA) AVG 10Y
15.24%
RETURN ON ASSETS (ROA) AVG 15Y
14.04%
RETURN ON ASSETS (ROA) AVG 20Y
12.43%
CURRENT VS TTM AVG
-63.59%
CURRENT VS 3Y AVG
-60.36%
CURRENT VS 5Y AVG
-57.44%
CURRENT VS 10Y AVG
-52.43%
CURRENT VS 15Y AVG
-48.35%
CURRENT VS 20Y AVG
-41.70%
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+46.76%
vs the sector median at left
Edwards Lifesciences Corporation
Market Cap
$53.52B
Return on Assets (ROA)
7.25%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
Market Cap
$55.48B
Return on Assets (ROA)
2.72%
TTM Avg
0.69%
3Y Avg
1.84%
5Y Avg
0.83%
Market Cap
$49.76B
Return on Assets (ROA)
1.85%
TTM Avg
3.00%
3Y Avg
3.04%
5Y Avg
2.95%
Market Cap
$45.13B
Return on Assets (ROA)
33.11%
TTM Avg
29.29%
3Y Avg
27.30%
5Y Avg
27.52%
Market Cap
$42.08B
Return on Assets (ROA)
10.82%
TTM Avg
10.56%
3Y Avg
11.14%
5Y Avg
10.55%
Market Cap
$40.06B
Return on Assets (ROA)
4.60%
TTM Avg
4.82%
3Y Avg
4.76%
5Y Avg
4.01%
Market Cap
$72.58B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation (EW) | $53.52B | 7.25% | 19.91% | 18.29% | 17.04% |
| Cardinal Health, Inc. (CAH)vs › | $55.48B | 2.72% | 0.69% | 1.84% | 0.83% |
| Becton, Dickinson and Company (BDX)vs › | $49.76B | 1.85% | 3.00% | 3.04% | 2.95% |
| Humana Inc. (HUM)vs › | $46.29B | 2.23% | 2.52% | 4.20% | 5.49% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $45.13B | 33.11% | 29.29% | 27.30% | 27.52% |
| Cencora, Inc. (COR)vs › | $62.03B | 3.13% | 2.14% | 2.52% | 0.85% |
| Agilent Technologies, Inc. (A)vs › | $42.08B | 10.82% | 10.56% | 11.14% | 10.55% |
| IQVIA Holdings Inc. (IQV)vs › | $40.06B | 4.60% | 4.82% | 4.76% | 4.01% |
| Cigna Corporation (CI)vs › | $72.58B | 4.08% | 2.99% | 3.50% | 3.82% |
| DexCom, Inc. (DXCM)vs › | $34.07B | 15.49% | 11.04% | 9.26% | 8.83% |
ROA
7.3%
ROE
9.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 7.84% |
| 2024-12-31 | 31.98% |
| 2023-12-31 | 14.98% |
| 2022-12-31 | 18.35% |
| 2021-12-31 | 17.68% |
| 2020-12-31 | 11.38% |
| 2019-12-31 | 16.14% |
| 2018-12-31 | 13.57% |
| 2017-12-31 | 10.92% |
| 2016-12-31 | 12.63% |
| 2015-12-31 | 12.19% |
| 2014-12-31 | 23.01% |
| 2013-12-31 | 14.38% |
| 2012-12-31 | 13.20% |
| 2011-12-31 | 11.95% |
| 2010-12-31 | 12.34% |
| 2009-12-31 | 14.18% |
| 2008-12-31 | 9.21% |
| 2007-12-31 | 8.40% |
| 2006-12-31 | 10.47% |
| 2005-12-31 | 6.45% |
| 2004-12-31 | 0.15% |
| 2003-12-31 | 7.17% |
| 2002-12-31 | 5.52% |
| 2001-12-31 | -1.23% |
| 2000-12-31 | -25.00% |
| 1999-12-31 | 5.71% |
